Aaron Beach

Aaron Beach is Director, Analytical Development at Verve Therapeutics. He has extensive biochemistry experience with a focus on producing and characterizing recombinant proteins and lipid nanoparticles. Prior to joining Verve, Mr. Beach served as principal scientist and investigator at the Novartis Institute for Biomedical Research, where he spent five years in positions of increasing responsibility. Most recently, Mr. Beach’s work focused on developing robust analytical methods for biological therapeutics and their transfer to clinical development. Previously, he held research positions at Dow AgroSciences and Biogen Idec. Mr. Beach received his B.S. in biochemistry at the University of Dayton.